Prospective observational study to describe routine use of XGEVAâ for prevention of skeletal related events (SREs) in subjects with bone metastases from prostate carcinoma in Bulgaria (20180095)

19/12/2018
17/04/2023
EU PAS number:
EUPAS26983
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20180095_01.02.06 Public Redacted Protocol Ver 1.0 2018-10-24 English

English (255.48 KB - PDF) View document
Study results
Study results

20180095 01.47.01.01 Observational Research Study Report Published Report_Redacted

English (492.48 KB - PDF) View document
Study report
Other information